1. Home
  2. INVZ vs ADCT Comparison

INVZ vs ADCT Comparison

Compare INVZ & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVZ
  • ADCT
  • Stock Information
  • Founded
  • INVZ 2016
  • ADCT 2011
  • Country
  • INVZ Israel
  • ADCT Switzerland
  • Employees
  • INVZ N/A
  • ADCT N/A
  • Industry
  • INVZ Auto Parts:O.E.M.
  • ADCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVZ Consumer Discretionary
  • ADCT Health Care
  • Exchange
  • INVZ Nasdaq
  • ADCT Nasdaq
  • Market Cap
  • INVZ 154.6M
  • ADCT 131.8M
  • IPO Year
  • INVZ N/A
  • ADCT 2020
  • Fundamental
  • Price
  • INVZ $0.57
  • ADCT $1.24
  • Analyst Decision
  • INVZ Strong Buy
  • ADCT Strong Buy
  • Analyst Count
  • INVZ 5
  • ADCT 5
  • Target Price
  • INVZ $3.24
  • ADCT $7.75
  • AVG Volume (30 Days)
  • INVZ 3.3M
  • ADCT 360.3K
  • Earning Date
  • INVZ 05-07-2025
  • ADCT 03-27-2025
  • Dividend Yield
  • INVZ N/A
  • ADCT N/A
  • EPS Growth
  • INVZ N/A
  • ADCT N/A
  • EPS
  • INVZ N/A
  • ADCT N/A
  • Revenue
  • INVZ $24,268,000.00
  • ADCT $70,837,000.00
  • Revenue This Year
  • INVZ $135.37
  • ADCT $11.56
  • Revenue Next Year
  • INVZ $132.60
  • ADCT $17.03
  • P/E Ratio
  • INVZ N/A
  • ADCT N/A
  • Revenue Growth
  • INVZ 16.25
  • ADCT 1.84
  • 52 Week Low
  • INVZ $0.45
  • ADCT $1.22
  • 52 Week High
  • INVZ $3.14
  • ADCT $5.38
  • Technical
  • Relative Strength Index (RSI)
  • INVZ 28.86
  • ADCT 29.96
  • Support Level
  • INVZ $0.59
  • ADCT $1.28
  • Resistance Level
  • INVZ $0.76
  • ADCT $1.68
  • Average True Range (ATR)
  • INVZ 0.05
  • ADCT 0.11
  • MACD
  • INVZ 0.01
  • ADCT -0.05
  • Stochastic Oscillator
  • INVZ 9.57
  • ADCT 3.88

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

Share on Social Networks: